Systemic inflammatory response and calcification markers in patients with long lasting moderate-severe chronic spontaneous urticaria

被引:22
|
作者
Grzanka, Alicja [1 ]
Machura, Edyta [2 ]
Misiolek, Maciej [3 ]
Polaniak, Renata [4 ]
Kasperski, Jacek [5 ]
Kasperska-Zajac, Alicja [1 ]
机构
[1] Med Univ Silesia, Dept Internal Dis Dermatol & Allergol, PL-41813 Zabrze, Poland
[2] Med Univ Silesia, Dept Pediat, PL-41813 Zabrze, Poland
[3] Med Univ Silesia, Clin Dept Otolaryngol Zabrze, Katowice, Poland
[4] Med Univ Silesia, Fac Publ Hlth Bytom, Dept Human Nutr, Katowice, Poland
[5] Med Univ Silesia, Dept Prosthet Dent Bytom, Katowice, Poland
关键词
matrix Gla Protein; chronic spontaneous urticaria; acute phase response; calcification; chronic inflammation; CORONARY-ARTERY CALCIFICATION; PROTEIN; SERUM;
D O I
10.1684/ejd.2014.2474
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: Low grade inflammation is associated with both chronic spontaneous urticaria (CSU) and atherosclerosis. Data regarding an association between urticarial inflammation and atherosclerosis and subsequent cardiovascular events are scarce. It has been demonstrated that matrix GLA protein (MGP), a biomarker of arterial calcification, is increased in patients with atherosclerosis. Objectives: To evaluate circulating levels of markers of arterial calcification and acute phase response (APR) in patients with CSU. Methods: Concentrations of MGP and IL-6 were measured in venous blood samples of patients with long-lasting moderate-severe CSU. Results: There were no significant differences in serum MGP concentration between healthy subjects and CU patients. Serum IL-6 concentration was significantly higher in CSU patients as compared with healthy subjects. Conclusions: The results confirm that CSU is accompanied by a low grade systemic inflammatory state. However, the long lasting urticarial inflammation was not paralleled by an increased circulating level of the calcification marker matrix Gla protein.
引用
收藏
页码:26 / 28
页数:3
相关论文
共 50 条
  • [1] Systemic inflammatory response and calcification markers in patients with long lasting moderate-severe chronic spontaneous urticaria
    Alicja Grzanka
    Edyta Machura
    Maciej Misiolek
    Renata Polaniak
    Jacek Kasperski
    Alicja Kasperska-Zajac
    European Journal of Dermatology, 2015, 25 : 26 - 28
  • [2] Multiple comorbidities in patients with long-lasting chronic spontaneous urticaria
    Agondi, Rosana Camara
    Argolo, Paula Natassya
    Mousinho-Fernandes, Mariana
    Gehlen, Bruna
    Kalil, Jorge
    Motta, Antonio Abilio
    ANAIS BRASILEIROS DE DERMATOLOGIA, 2023, 98 (01) : 93 - 96
  • [3] Ligelizumab achieves high rate of complete response in patients with moderate to severe chronic spontaneous urticaria
    Bernstein, J. A.
    Maurer, M.
    Gimenez-Arnau, A.
    Soong, W.
    Sussman, G.
    Metz, M.
    Lanier, B.
    Sitz, K.
    Hide, M.
    Hua, E.
    Barve, A.
    Severin, T.
    Janocha, R.
    ALLERGY, 2020, 75 : 84 - 85
  • [4] Ligelizumab Achieves High Rate of Complete Response in Patients with Moderate to Severe Chronic Spontaneous Urticaria
    Bernstein, J.
    Maurer, M.
    Gimenez-Arnau, A.
    Soong, W.
    Sussman, G.
    Metz, M.
    Lanier, B.
    Sitz, K.
    Hide, M.
    Manetsch, M.
    Hua, E.
    Barve, A.
    Severin, T.
    Janocha, R.
    SWISS MEDICAL WEEKLY, 2021, 151 : 12S - 12S
  • [5] Systemic inhibition of p38 MAPK improves lung function and inflammatory markers in moderate-severe COPD
    Danto, Spencer
    Langdon, Grant
    Shojaee, Negin
    Christensen, Jared
    Clarke, Nick
    Tan, Lisa
    Perros-Huguet, Christelle
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [6] High rate of complete response with ligelizumab in adults with moderate-to-severe chronic spontaneous urticaria
    Bernstein, J. A.
    Maurer, M.
    Gimenez-Arnau, A.
    Soong, W.
    Sussman, G.
    Metz, M.
    Lanier, B.
    Sitz, K.
    Hide, M.
    Hua, E.
    Barve, A.
    Severin, T.
    Janocha, R.
    BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 : 57 - 57
  • [7] Efficacy of bilastine updosing in refractory moderate to severe chronic spontaneous urticaria
    Weller, K.
    Andre, F.
    Schoepke, N.
    Ohanyan, T.
    Zuberbier, T.
    Maurer, M.
    ALLERGY, 2016, 71 : 298 - 299
  • [8] Activation of the coagulation cascade and response to omalizumab in patients with severe chronic spontaneous urticaria
    Asero, R.
    Marzano, A., V
    Ferrucci, S.
    Genovese, G.
    Cugno, M.
    ALLERGY, 2019, 74 : 164 - 165
  • [9] New markers to predict the response to omalizumab in chronic spontaneous urticaria
    Cosansu, Nur Cihan
    Kara, Rabia Oztas
    Yaldiz, Mahizer
    Dikicier, Bahar Sevimli
    DERMATOLOGIC THERAPY, 2022, 35 (08)
  • [10] Evaluation of carotid intima media thickness and hematologic inflammatory markers in patients with chronic spontaneous urticaria
    Yaldiz, Mahizer
    Asil, Kiyasettin
    POSTEPY DERMATOLOGII I ALERGOLOGII, 2020, 37 (02): : 214 - 220